Dx Dialogues: Multiple Myeloma

In these videos, hematologist and medical oncologist Dr. Sborov discusses key considerations in advancing myeloma therapy, including identifying patients for combination therapies incorporating CAR-T cell therapy, exploring versatile treatment approaches for refractory disease, and examining strategies to optimize long-term outcomes following anti-CD38 therapy. He also highlights novel strategies to overcome resistance and delves into emerging therapeutic options that are shaping the future of myeloma treatment.